⚖UPC-Intel
🏛️ EPO Munich

EPO T 0251/25

Court
EPO Board of Appeal 3.3.04 (Munich)
Type of action
opposition appeal
Patent
EP2981255
Therapeutic uses of empagliflozin
Language
en
Claimant / applicant
  • Boehringer Ingelheim International GmbH
Defendant / respondent
  • TEVA PHARMACEUTICAL INDUSTRIES, LTD.
  • ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
  • SANDOZ AG
  • Zentiva k.s.
  • STADA Arzneimittel AG
  • Sanovel IIaç San. ve Tic. A.S
  • Adalvo Ltd.
  • Aera A/S
  • HGF Limited
  • Generics (U.K.) Limited
  • Dr Reddy's Laboratories (UK) Limited

Track this case

Get an email when a new order or decision is published in EPO T 0251/25.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.